Skip to main content

Mpox clinical trials at University of California Health

1 research study open to eligible people

Showing trials for
  • Tecovirimat for Human Monkeypox Virus

    open to all eligible people

    A5418 is a randomized, placebo-controlled, double-blind study to establish the efficacy of tecovirimat for the treatment of people with laboratory-confirmed or presumptive HMPXV disease.

    at UC Davis UCLA UCSD UCSF

Last updated: